Skip to main content

MoneyWorks4Me

Amerise Biosciences - Quaterly Results

04 May 2023 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended March 2023. The figure stood at Rs. 65.66 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -0.20 millions as compared to Net Profit of Rs. 2.85 millions of corresponding quarter ended March 2022Operating profit Margin for the quarter ended March 2023 slipped to -0.20% as compared to 2.85% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 0.00 65.66 0.00 0.09 95.77 -99.91 0.09 95.77 -99.91
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.20 2.85 -107.02 -1.19 5.48 -121.72 -1.19 5.48 -121.72
Equity 66.07 66.07 0.00 66.07 66.07 0.00 66.07 66.07 0.00
PBIDTM(%) 0.00 4.34 0.00 -1322.22 5.72 -23207.69 -1322.22 5.72 -23207.69
Peers
Company Name CMP
Bajaj Finserv 1849.45
TVS Holdings 13058.00
Cholamandalam Fin. 1455.25
Altius Telecom Infra 172.00
Kama Holdings 2140.00
View more..